<p>APOLLO is a proteogenomic study seeking to describe the major genome, transcriptome, proteome and phosphoproteome alterations, subtypes, and molecular predictors of patient outcomes. This study includes 70 high grade serous ovarian carcinoma tissues from the Gynecologic Cancer Center of Excellence (https://medschool.usuhs.edu/gso/research/gyn-cancer-center-of-excellence). Bulk and laser microdissection enriched tumor tissues were profiled by whole genome sequencing, transcriptome sequencing, MS-based proteomics and reverse phase protein arrays. Clinical and sample data include survival times, patient features, and tumor characteristics.</p><p> </p>

APOLLO-OV: Applied Proteogenomics of High Grade Serous Ovarian Carcinoma

Ovarian Neoplasms study on CRDC (70 participants)

APOLLO-OV: Applied Proteogenomics of High Grade Serous Ovarian Carcinoma

Description

Applying For Access

Summary